Skip to Content

ROCHE HIVID 0.750 (Hivid 0.75 mg)

Generic Name: zalcitabine

Pill with imprint ROCHE HIVID 0.750 is White, Elliptical / Oval and has been identified as Hivid 0.75 mg. It is supplied by Roche Laboratories.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ROCHE HIVID 0.750

Hivid

Generic Name
zalcitabine
Imprint
ROCHE HIVID 0.750
Strength
0.75 mg
Color
White
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roche Laboratories
National Drug Code (NDC)
00004-0221

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.